Response of ALL cell lines demonstrates differential sensitivity to ABT-737 treatment. (A) 106 cells were treated in triplicate with increasing amounts of ABT-737. Apoptosis was assessed by counting annexin-V–positive cells by FACS analysis. (B) EC50 values were plotted against the BAD BH3 peptide cytochrome c release values for each line.